Taisho Pharmaceutical Holdings Co., Ltd.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
1/10
|
644017240.62 | 111.03 | 580036971.95% | 318387703.58 | +102.27% |
| P/S |
|
40594448.62 | 75.03 | 54106147.5% |
|
|
| P/BV |
|
15116453.12 | 70.29 | 21507265.69% |
|
|
| P/FCF |
|
-47.11 | 80.52 | -158.51% |
|
|
| Ev/Ebitda |
|
221292827.6 | 76.71 | 288485919.08% |
|
|
| Ev/S |
|
40594447.78 | 72.43 | 56044546.94% |
|
|
| Ev/FCF |
|
-1300562907.05 | 15.5 | -8392506090.21% |
|
|
| E/P |
|
0.0429 | 0.1179 | -63.62% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
6/10
|
18.34 | -78.2 | -123.46% | 18.8 | -2.4% |
| ROE |
|
2.42 | -10.46 | -123.1% |
|
|
| ROA |
|
2.02 | -10.03 | -120.11% |
|
|
| ROIC |
|
0 | 9.09 | -100% |
|
|
| ROS |
|
6.3 | -143.89 | -104.38% |
|
|
| ROCE |
|
3.79 | 2.34 | 61.52% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0.0468 | 1.08 | -95.65% | 0.0612 | -23.41% |
| Nеt Debt/Ebitda |
|
-4.58 | -0.3908 | 1072.58% |
|
|
| Debt/Ratio |
|
0.0028 | 0.1308 | -97.9% |
|
|
| Debt/Equity |
|
0.0183 | 6.92 | -99.73% |
|
|
| Debt/Net Income |
|
0.1363 | -1.84 | -107.4% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 2.62 | -100% | 1.08 | -100% |
| Number of years of dividend growth |
|
0 | 1.16 | -100% | ||
| DSI |
|
0.8571 | 0.7238 | 18.42% |
|
|
| Average dividend growth |
|
-9.37 | -10.93 | -14.28% |
|
|
| Average percentage for 5 years |
|
1.08 | 1.88 | -42.54% |
|
|
| Average percentage for payments |
|
44.03 | 37.94 | 16.05% |
|
|
| Difference from average difference in sector |
|
-2.62 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
3/10
|
15.31 | 170.19 | -91% | ||
| Growth impulse Ebitda in 5 years |
|
-25.83 | 101.21 | -125.52% | ||
| Growth impulse Net Income in 5 years |
|
-60.9 | 82.55 | -173.77% | ||
| Growth impulse FCF in 5 years |
|
-165.74 | 104.08 | -259.24% | ||
| Growth impulse EPS in 5 years |
|
-61.95 | 127.91 | -148.43% |
IP Score
3.49/10
